{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:22:09Z","timestamp":1791256929090,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000165","name":"Sick Kids Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.clim.2006.02.003","type":"journal-article","created":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T07:17:08Z","timestamp":1143271028000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Towards subtlety: Understanding the role of Toll-like receptor signaling in susceptibility to human infections"],"prefix":"10.1016","volume":"120","author":[{"given":"Stuart E.","family":"Turvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Hawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.02.003_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2005.03.053","article-title":"From idiopathic infectious diseases to novel primary immunodeficiencies","volume":"116","author":"Casanova","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.clim.2006.02.003_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","article-title":"The dorsoventral regulatory gene cassette spatzle\/Toll\/cactus controls the potent antifungal response in Drosophila adults","volume":"86","author":"Lemaitre","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.clim.2006.02.003_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.170.1.438","article-title":"Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis","volume":"170","author":"Koedel","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.163.1.1","article-title":"Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2","volume":"163","author":"Yoshimura","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib8","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.172.5.3132","article-title":"Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense","volume":"172","author":"Knapp","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib9","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1073\/pnas.0435928100","article-title":"Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection","volume":"100","author":"Malley","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.02.003_bib10","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1074\/jbc.M212829200","article-title":"Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved","volume":"278","author":"Schroder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2006.02.003_bib11","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1128\/IAI.73.10.6479-6487.2005","article-title":"The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease","volume":"73","author":"Srivastava","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2006.02.003_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/316914","article-title":"A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)","volume":"67","author":"Zonana","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y","article-title":"Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection","volume":"99","author":"Mansour","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib17","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.clim.2006.02.003_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2004.06.052","article-title":"Human nuclear factor kappaB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia","volume":"114","author":"Orange","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jaci.2004.08.047","article-title":"Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia","volume":"114","author":"Niehues","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/adc.88.4.340","article-title":"Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO","volume":"88","author":"Carrol","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2006.02.003_bib22","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1542\/peds.109.6.e97","article-title":"Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother","volume":"109","author":"Dupuis-Girod","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.clim.2006.02.003_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI18714","article-title":"A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency","volume":"112","author":"Courtois","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.02.003_bib25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1086\/428733","article-title":"Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency","volume":"40","author":"Chapel","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jpeds.2003.10.034","article-title":"Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling","volume":"144","author":"Currie","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2006.02.003_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.20030701","article-title":"Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections","volume":"198","author":"Medvedev","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.02.003_bib28","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.clim.2006.02.003_bib29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpeds.2004.06.065","article-title":"Two siblings with lethal pneumococcal meningitis in a family with a mutation in Interleukin-1 receptor-associated kinase 4","volume":"145","author":"Enders","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2006.02.003_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jpeds.2003.11.025","article-title":"Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses","volume":"144","author":"Day","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2006.02.003_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.immuni.2005.09.016","article-title":"Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha\/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses","volume":"23","author":"Yang","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2006.02.003_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coi.2003.11.013","article-title":"Inherited disorders of NF-kappaB-mediated immunity in man","volume":"16","author":"Puel","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM198803243181202","article-title":"Genetic and environmental influences on premature death in adult adoptees","volume":"318","author":"Sorensen","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2006.02.003_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaci.2004.06.044","article-title":"Primary immunodeficiency diseases: an update","volume":"114","author":"Notarangelo","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/4371241a","article-title":"Genomics: understanding human diversity","volume":"437","author":"Goldstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2006.02.003_bib36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/35103577","article-title":"Genetics of susceptibility to human infectious disease","volume":"2","author":"Cooke","year":"2001","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1399-0004.2000.580402.x","article-title":"Single nucleotide polymorphisms and the future of genetic epidemiology","volume":"58","author":"Schork","year":"2000","journal-title":"Clin. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib38","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1093\/hmg\/ddh225","article-title":"Genetics of infectious diseases","volume":"13","author":"Frodsham","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0966-842X(03)00207-5","article-title":"Genetic susceptibility to infectious disease","volume":"11","author":"Segal","year":"2003","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.clim.2006.02.003_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.genom.2.1.373","article-title":"The genomics and genetics of human infectious disease susceptibility","volume":"2","author":"Hill","year":"2001","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(02)08516-1","article-title":"MBL genotype and risk of invasive pneumococcal disease: a case\u2013control study","volume":"359","author":"Roy","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2006.02.003_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/313588","article-title":"Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia","volume":"30","author":"Yee","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib43","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archpsyc.62.11.1186","article-title":"Translational research on the way to effective therapy for Alzheimer disease","volume":"62","author":"Rosenberg","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.clim.2006.02.003_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001432-200402000-00003","article-title":"Co-receptor antagonists as HIV-1 entry inhibitors","volume":"17","author":"Shaheen","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jhep.2001.22347","article-title":"Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection","volume":"33","author":"Yee","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clim.2006.02.003_bib46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutations are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib48","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1084\/jem.20022078","article-title":"Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling","volume":"197","author":"Erridge","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.02.003_bib49","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1086\/378095","article-title":"Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood","volume":"188","author":"von Aulock","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib50","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archinte.162.9.1028","article-title":"Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock","volume":"162","author":"Lorenz","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clim.2006.02.003_bib51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1086\/344893","article-title":"Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections","volume":"186","author":"Agnese","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib52","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1073\/pnas.1031605100","article-title":"Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility","volume":"100","author":"Smirnova","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.02.003_bib53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib54","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1086\/420830","article-title":"Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease","volume":"189","author":"Tal","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib55","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1073\/pnas.0409831102","article-title":"Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires\u2019 disease","volume":"102","author":"Hawn","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.02.003_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1242\/jcs.00212","article-title":"Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2","volume":"116","author":"Girard","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.clim.2006.02.003_bib57","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJM200212123472416","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis","volume":"347","author":"Cooke","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2006.02.003_bib58","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/322798","article-title":"A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease","volume":"184","author":"Read","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1183\/09031936.03.00061703","article-title":"The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease","volume":"23","author":"Ogus","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2006.02.003_bib60","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4049\/jimmunol.175.4.2534","article-title":"Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease","volume":"175","author":"Schroder","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib61","first-page":"1194","article-title":"Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus","volume":"11","author":"Moore","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.gene.6364274","article-title":"The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans","author":"Yim","year":"2006","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2006.02.003_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1574-695X.2001.tb01586.x","article-title":"Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients","volume":"31","author":"Kang","year":"2001","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.clim.2006.02.003_bib64","first-page":"625","article-title":"Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients","volume":"11","author":"Ben-Ali","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.clim.2006.02.003_bib65","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00439-004-1249-9","article-title":"TLR2 Arg677Trp polymorphism in leprosy: revisited","volume":"116","author":"Malhotra","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clim.2006.02.003_bib66","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1084\/jem.20031220","article-title":"A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires\u2019 disease","volume":"198","author":"Hawn","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.02.003_bib67","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/428593","article-title":"Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam","volume":"191","author":"Dunstan","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2006.02.003_bib68","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2567.2003.01674.x","article-title":"Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis","volume":"109","author":"Feterowski","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2006.02.003_bib69","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.inf.0000195595.22547.fe","article-title":"Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy","volume":"25","author":"Faber","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.clim.2006.02.003_bib70","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1128\/IAI.68.11.6398-6401.2000","article-title":"A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection","volume":"68","author":"Lorenz","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2006.02.003_bib71","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.inf.0000095431.15606.68","article-title":"Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children","volume":"22","author":"Allen","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.clim.2006.02.003_bib72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0506803102","article-title":"Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria","volume":"103","author":"Mockenhaupt","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.02.003_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tube.2004.02.001","article-title":"The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia","volume":"84","author":"Newport","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.clim.2006.02.003_bib74","article-title":"TLR4 polymorphism in Iranian patients with brucellosis","author":"Rezazadeh","year":"2005","journal-title":"J. Infect."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:55:12Z","timestamp":1761494112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661606000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1521661606000507"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.02.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards subtlety: Understanding the role of Toll-like receptor signaling in susceptibility to human infections","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2006.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}